Y-12 Federal Credit Union Upgrades Fleet, Enhances Self-Service Banking with NCR Atleos
Specifically, Y-12 FCU decided to upgrade its entire fleet of self-service devices from a mix of ATMs and interactive teller machines (ITMs), to all Atleos ITMs. With this transition, Y-12 FCU was able to migrate transactions from the branch to the self-service channel, to drive efficiencies and a better and more convenient member experience. ITMs are essentially an ATM with live video chat that offers a virtual version of the in-person banking experience.
Y-12 FCU and Atleos have enjoyed a longstanding successful relationship, with the credit union proving to be a pioneer in embracing ITMs or Personal Teller Machines as they are called by Y-12 FCU. The initial deployment of ITMs was very effective for Y-12 FCU, that's why the credit union decided to upgrade its entire fleet to ITMs. As part of this transformation, the credit union is also enabling members to initiate transactions via contactless cards and mobile devices.
"Teaming with Atleos has helped us further deliver on our mission to provide a seamless combination of digital convenience and personal interaction," said Todd Richardson, CTO of Y-12 FCU. "We want members to choose what works best for them -- some prefer self-service, while others value a human touch. And with our upgraded ITM fleet, we are also able to quickly deploy more innovative features to our members, ensuring their banking is simple and accessible, all while reducing costs and complexities in the back office."
"Atleos is the leader in helping credit unions efficiently and effectively facilitate self-service banking for their members, ultimately expanding financial access," said Steven Nogalo, general manager of North America for Atleos. "We are proud of our successful relationship with Y-12 FCU, who remains committed to utilizing the advanced technology needed to enable members to bank when and how they choose."
About Atleos
Atleos (NYSE: NATL) is a leader in expanding self-service financial access, with industry-leading ATM expertise and experience, unrivalled operational scale including the largest independently-owned ATM network, always-on global services and constant innovation. Atleos improves operational efficiency for financial institutions, drives footfall for retailers and enables digital-first financial self-service experiences for consumers. Atleos is headquartered in Atlanta, Georgia, with approximately 20,000 employees globally.
Web site: https://www.ncratleos.com X (Twitter): https://twitter.com/ncratleos Facebook: https://www.facebook.com/Atleos.NCR/ LinkedIn: https://www.linkedin.com/company/ncratleos YouTube: https://www.youtube.com/@ncratleos Instagram: https://www.instagram.com/ncratleos/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250331192376/en/
Contacts
Media Contact Scott SykesNCR Atleosscott.sykes@ncratleos.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
an hour ago
- Business Insider
SM Energy (SM) Gets a Hold from Wells Fargo
Wells Fargo analyst Hanwen Chang maintained a Hold rating on SM Energy on July 18 and set a price target of $30.00. The company's shares closed last Friday at $25.89. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Chang covers the Energy sector, focusing on stocks such as Vital Energy, Matador Resources, and SM Energy. According to TipRanks, Chang has an average return of -2.8% and a 38.24% success rate on recommended stocks. In addition to Wells Fargo, SM Energy also received a Hold from J.P. Morgan's Zach Parham in a report issued on July 10. However, on July 16, Siebert Williams Shank & Co maintained a Buy rating on SM Energy (NYSE: SM). Based on SM Energy's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $844.54 million and a net profit of $182.27 million. In comparison, last year the company earned a revenue of $559.87 million and had a net profit of $131.2 million Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is neutral on the stock. Last month, Richard A. Jenkins, the SVP – Utah of SM sold 7,726.00 shares for a total of $220,113.74.
Yahoo
an hour ago
- Yahoo
Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT
AbbVie Inc. (NYSE:ABBV) is one of the best long term low volatility stocks to buy now. On July 10, Morgan Stanley analyst Terrence Flynn reiterated a Buy rating on AbbVie Inc. (NYSE:ABBV) and set a price target of $250.00. A pharmacist handing out a pharmaceutical drug to a patient in a drug store or chemist. AbbVie Inc. (NYSE:ABBV) reported positive fiscal Q1 2025 results that support the optimistic outlook, with adjusted diluted EPS reaching $2.46, experiencing a 6.5% growth. The company also reported $13.343 billion in net revenue for the first quarter of 2025, reflecting an 8.4% growth on a reported basis or 9.8% on an operational basis. AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology, and various other serious health conditions. While we acknowledge the potential of ABBV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
an hour ago
- Yahoo
Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best long term low volatility stocks to buy now. On July 16, Thermo Fisher Scientific Inc. (NYSE:TMO) announced plans to strategically expand its partnership with Sanofi to support additional drug product manufacturing in the United States. A workstation in a research lab stocked with laboratory products and services. As part of the partnership, Thermo Fisher Scientific Inc. (NYSE:TMO) would acquire Sanofi's manufacturing site in Ridgefield, New Jersey, and would continue to produce and develop a portfolio of therapies for Sanofi. Thermo Fisher Scientific Inc. (NYSE:TMO) also plans to expand use of the site to satisfy the rising demand from biotech and pharma customers for US manufacturing capacity. The Ridgefield site will join Thermo Fisher Scientific Inc. (NYSE:TMO) after the completion of the transaction, and comprises a state-of-the-art sterile fill-finish and packaging facility with over 200 employees. Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. It operates through the Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics segments. While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.